Oncolytics Biotech Ownership | Who Owns Oncolytics Biotech?

Oncolytics Biotech Ownership Summary

Oncolytics Biotech is owned by 1.00% institutional investors, and 99.00% retail investors. Morgan stanley is the largest institutional shareholder, holding 0.42% of ONCY shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.07% of its assets in Oncolytics Biotech shares.

ONCY Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Oncolytics Biotech	1.00%	-	99.00%
Sector	Healthcare Stocks	42.64%	10.86%	46.50%
Industry	Biotech Stocks	45.45%	10.77%	43.78%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Morgan stanley	383.35K	0.42%	$536.68K
Marshall wace, llp	323.98K	0.36%	$453.57K
Seeds investor	258.31K	0.26%	$225.76K
Goldman sachs group	208.70K	0.23%	$292.18K
International assets investment management	208.15K	0.21%	$181.92K
Citadel advisors	137.09K	0.18%	$135.71K
Quadrature capital	106.08K	0.12%	$146.38K
Franklin resources	69.84K	0.08%	$71.25K
Royal bank of canada	68.23K	0.07%	$96.00K
Geode capital management	66.94K	0.07%	$93.71K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Ground swell capital	34.40K	0.06%	$30.06K
Seeds investor	258.31K	0.04%	$225.76K
Ball & co wealth management	38.25K	0.02%	$33.00K
International assets investment management	208.15K	0.01%	$181.92K
Vantage point financial	29.74K	0.01%	$26.00K
Scientech research	18.20K	0.01%	$25.49K
Headinvest	44.70K	0.01%	$39.07K
Brave asset management	25.00K	0.01%	$21.85K
Seacrest wealth management	32.00K	0.00%	$30.74K
Professional advisory services	20.00K	0.00%	$17.00K

Top Buyers

Holder	Shares	% Assets	Change
Morgan stanley	383.35K	-	364.49K
Marshall wace, llp	323.98K	0.00%	323.98K
Quadrature capital	106.08K	0.00%	106.08K
Goldman sachs group	208.70K	-	78.50K
Lpl financial	51.35K	-	51.35K

Top Sellers

Holder	Shares	% Assets	Change
Virtu financial	-	-	-98.45K
Millennium management	-	-	-40.89K
Commonwealth equity services	25.11K	-	-40.00K
Long focus capital management	-	-	-40.00K
Citadel advisors	137.09K	-	-25.68K

New Positions

Holder	Shares	% Assets	Change	Value
Marshall wace, llp	323.98K	0.00%	323.98K	$453.57K
Quadrature capital	106.08K	0.00%	106.08K	$146.38K
Ground swell capital	34.40K	0.06%	34.40K	$30.06K
Alphacore capital	22.50K	0.00%	22.50K	$19.66K
Rockefeller capital management	20.94K	0.00%	20.94K	$29.32K

Sold Out

Holder	Change
Russell investments group	-1.00
Pacifica partners	-100.00
Ifp advisors	-100.00
Citigroup	-333.00
Ameritas advisory services	-750.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	30	-43.40%	910,881	-32.37%	1	39.52%	5	-76.19%	2	-60.00%
Jun 30, 2025	55	12.24%	1,492,518	10.47%	1	55.94%	23	9.52%	5	-28.57%
Mar 31, 2025	50	8.70%	1,365,517	3.85%	1	60.09%	22	-8.33%	7	-
Dec 31, 2024	27	-35.71%	736,398	-38.42%	-	39.18%	14	-	2	-77.78%
Sep 30, 2024	41	-	1,193,430	-8.85%	1	51.80%	14	-22.22%	9	12.50%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Nasdaq Composite Index	66.94K	0.07%	-
Vifag 2002 SICAV	30.00K	0.04%	-

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-

ONCY Ownership FAQ

Who Owns Oncolytics Biotech?

Oncolytics Biotech shareholders are primarily institutional investors at 1.00%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Oncolytics Biotech's industry, Biotech Stocks , is 45.45%, which Oncolytics Biotech falls below.

Who owns the most shares of Oncolytics Biotech?

Oncolytics Biotech’s largest shareholders are Morgan stanley (383.35K shares, 0.42%), Marshall wace, llp (323.98K shares, 0.36%), and Seeds investor (258.31K shares, 0.26%). Together, they hold 1.03% of Oncolytics Biotech’s total shares outstanding.

Does Blackrock own Oncolytics Biotech?

BlackRock is not among the top 10 institutional shareholders of Oncolytics Biotech.

Who is Oncolytics Biotech’s biggest shareholder by percentage of total assets invested?

Ground swell capital is Oncolytics Biotech’s biggest shareholder by percentage of total assets invested, with 0.06% of its assets in 34.4K Oncolytics Biotech shares, valued at 30.06K$.

Who is the top mutual fund holder of Oncolytics Biotech shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Oncolytics Biotech shares, with 0.07% of its total shares outstanding invested in 66.94K Oncolytics Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools